turbilatex

suPARnostic® is a prognostic biomarker useful for risk stratification of acute medical patients in the Emergency Department.

Important clinical benefits include;

  • Prioritization: Identifies patients who can be discharged after treatment
  • Safety: Identifies high-risk patients wih unaffected vital signs
  • Cost savings: Shortens the average patient-length-of-stay and reduces
    the cost of healthcare

 

The suPARnostic® TurbiLatex product is CE-IVD approved for the Roche Diagnostics Cobas c500 and c700 series.

The suPARnostic® TurbiLatex test is validtated on the Roche Cobas c501/c502/c701/c702 biochemistry analyzer.

ViroGates is planning to validate the suPARnostic® TurbiLatex test on other biochemistry analyzers such as Siemens and Abbott.

suPARnostic® TurbiLatex Reagents

Overview

The suPARnostic® TurbiLatex test is a latex particle-enhanced turbidimetric immunoassay that quantitatively determines suPAR in human EDTA- or Heparin plasma samples.

The suPARnostic® TurbiLatex product is validated for the Roche Cobas c501/c502/c701/c702 biochemistry analyzer.

Validation on other turbidimetric platforms will follow.

Product contains:
The reagents are ready-to-use.
The kit contains 20 mL of R1 and 8 mL of R2, sufficient for 100 tests including dead volume.


Benefits

  • Ready-to-use reagents
  • Automated, high throughput operation
  • Standarized test adding to the menu breadth
  • Timely results
  • LIS connectivity

 

Product Code

Product no. T001: suPARnostic® TurbiLatex Reagents

 

Price Quote

Please fill in the form here and we will send you a price quote

 

Documentation

Helpful documents


Performance Characteristics
 
Please see the Instructions for Use above.

More information about Sales & Support of suPARnostic® products here; How To Buy